LIG3 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P49916 |
---|---|
Clone Names | 100507266 |
Gene ID | 3980 |
---|---|
Other Names | DNA ligase 3, DNA ligase III, Polydeoxyribonucleotide synthase [ATP] 3, LIG3 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | LIG3 |
---|---|
Function | Isoform 3 functions as a heterodimer with DNA-repair protein XRCC1 in the nucleus and can correct defective DNA strand-break repair and sister chromatid exchange following treatment with ionizing radiation and alkylating agents. Isoform 1 is targeted to mitochondria, where it functions as a DNA ligase in mitochondrial base-excision DNA repair (PubMed:10207110, PubMed:24674627). |
Cellular Location | [Isoform 1]: Mitochondrion Note=Contains an N-terminal mitochondrial transit peptide [Isoform 3]: Nucleus. Note=Lacks the N-terminal mitochondrial transit peptide. |
Tissue Location | Testis, thymus, prostate and heart. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene is a member of the DNA ligase family. Eachmember of this family encodes a protein that catalyzes the joiningof DNA ends but they each have a distinct role in DNA metabolism.The protein encoded by this gene is involved in excision repair andis located in both the mitochondria and nucleus, with translationinitiation from the upstream start codon allowing for transport tothe mitochondria and translation initiation from a downstream startcodon allowing for transport to the nucleus. Additionally,alternate transcriptional splice variants, encoding differentisoforms, have been characterized.
References
Wang, W., et al. Nucleic Acids Res. (2010) In press :Arora, M., et al. Leukemia 24(8):1470-1475(2010)Cotner-Gohara, E., et al. Biochemistry 49(29):6165-6176(2010)Ho-Pun-Cheung, A., et al. Pharmacogenomics J. (2010) In press :Briggs, F.B., et al. Am. J. Epidemiol. 172(2):217-224(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.